Show simple item record

PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)

dc.contributor.authorRizo, A.
dc.contributor.authorKussick, S. J.
dc.contributor.authorMulligan, G.
dc.contributor.authorLeonard, J. P.
dc.contributor.authorFerhanoglu, B.
dc.contributor.authorOffner, F.
dc.contributor.authorReeves, J. A.
dc.contributor.authorEom, H. S.
dc.contributor.authorDoner, K.
dc.contributor.authorRaposo, J.
dc.contributor.authorFlinn, I. W.
dc.contributor.authorSuh, C.
dc.contributor.authorChowhan, N. M.
dc.contributor.authorPrasad, S.
dc.date.accessioned2021-03-04T18:01:21Z
dc.date.available2021-03-04T18:01:21Z
dc.identifier.citationOffner F., Ferhanoglu B., Reeves J. A. , Eom H. S. , Doner K., Raposo J., Flinn I. W. , Suh C., Chowhan N. M. , Prasad S., et al., "PHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)", 11th International Conference on Malignant Lymphoma, Lugano, İsviçre, 15 - 18 Haziran 2011, cilt.22, ss.225
dc.identifier.othervv_1032021
dc.identifier.otherav_8888a70b-31a8-439d-ad4a-9710c6e97cba
dc.identifier.urihttp://hdl.handle.net/20.500.12627/92645
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titlePHASE 2 STUDIES OF IMMUNOCHEMOTHERAPY +/- BORTEZOMIB (VC) IN NEWLY DIAGNOSED NON-GERMINAL CENTER B-CELL-LIKE (GCB) DLBCL: RAPID PROSPECTIVE IDENTIFICATION OF NON-GCB PATIENTS (PTS)
dc.typeBildiri
dc.contributor.departmentGhent University , ,
dc.identifier.volume22
dc.contributor.firstauthorID138284


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record